Skip to main content
Premium Trial:

Request an Annual Quote

Two More Institutions Join Open Bio RNAi Access Program

NEW YORK (GenomeWeb News) – Open Biosystems said today that University College London in the UK and the Toronto-based Hospital for Sick Kids have purchased access to the firm’s shRNAmir technologies for RNAi by joining the Open Access RNAi program.

According to a statement issued by the Huntsville, Al.-based firm, the two institutions purchased access to lentiviral shRNAmir libraries developed in collaboration with Greg Hannon and Steve Elledge and exclusively distributed through Open Biosystems.

Chris Boshoff, director of the UCL Cancer Institute, said that access to Open Bio’s RNAi access program is helping to foster collaboration between the cancer center and UCL Institutes for Child Health and Neurology, as well as UCL’s Division of Infection and Immunity.

Terms of the licenses were not disclosed.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.